HM vs Fibreglass Cast Immbolization for Supracondylar Fractures
NCT ID: NCT05430074
Last Updated: 2024-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
79 participants
INTERVENTIONAL
2022-08-16
2022-11-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
As the application method of HM and fibreglass casts are fundamentally different, it has not been reported if the difference in application duration between the cast materials is significant and its potential implications in outpatient clinic operation.
Hence, through a randomized controlled trial, this study primarily aims to investigate if the clinical outcomes, patient satisfaction and duration of cast application with the HM casts would be comparable with fibreglass casts in children with supracondylar humeral fractures.
Through this study, the investigators hope to evaluate the advantages and disadvantages of the respective casting material which may better aid physicians in deciding a more appropriate cast material for treating paediatric supracondylar humeral fractures with cast immobilization and the implications of casting duration on clinic operations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Type I Supracondylar Fractures of the Humerus
NCT00904137
Femoral Pediatric Fractures. Walking Spica Cast vs Synthetic Pants
NCT04311866
Management of Type 1 Supracondylar Humeral Fractures
NCT04642807
The Use of Telemedicine Tool in Supracondylar Humerus Fractures in Children
NCT02640027
The Wrist-Free Study - Comparing Traditional Above Elbow Casts to Ones That Free the Wrist
NCT06496672
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HM Cast
HM Cast
Subjects assigned to this arm will be treated via cast immobilisation with the use of HM casts.
Fibreglass Cast
Fibreglass Cast
Subjects assigned to this arm will be treated via cast immobilisation with the use of Fibreglass casts.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HM Cast
Subjects assigned to this arm will be treated via cast immobilisation with the use of HM casts.
Fibreglass Cast
Subjects assigned to this arm will be treated via cast immobilisation with the use of Fibreglass casts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Previous elbow injuries
* Open fractures
* Polytrauma
* Neurovascular injuries
0 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KK Women's and Children's Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kenneth Wong Pak Leung
Consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KK Women's and Children Hospital
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIRB Ref: 2022/2409
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.